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INTRODUCTION
Crimean-Congo haemorrhagic fever (CCHF) is a vi-
ral haemorrhagic disease caused by Nairovirus from
Bunyavirus family and proceeds with high fever and dif-
fuse bleeding. The disease transmits by tick bite, tick re-
moval and by contact with the cases in the acute period
of infection and with blood or tissues of viremic animal.
The disease which becomes increasingly widespread has
been identified in the middle east, western Europe, Asia
and Africa continents. In Turkey, an epidemic of uncer-
tain cause drew attention for the first time especially in
Tokat, and in Amasya and Sivas provinces with history
of tick contact, progressed with fever and bleeding
in the spring and summer months of 2002. The
disease was understood to be CCHF in 20031–2. The epi-
demic which has begun in 2002 is currently being
continued and according to the records of the Ministry of
Health, proven number of CCHF cases reached to 4453
as of 20093.
Infected mononuclear phagocytic cells, liver and en-
dothelial cells are known to play a crucial role in patho-
genesis of CCHF4. The disease courses subclinical in some
cases, while it may result in death with the development
of shock and disseminated intravascular coagulopathy
(DIC). Although similar genetic strains have been defined,
the causes of the clinical differences between the cases
are yet to be investigated.
Reactive oxygen species (ROS) occur in organisms
depending on several mechanisms. Energy metabolism
in the mitochondria, in active phagocytic leukocytes
causes production of superoxide, peroxide, hydroxyl and
other free radicals that are known as ROS and derived
from oxygen in hundreds of biological aerobic molecular
environment such as various enzymes (xanthine oxidase,
tryptophan dioxygenase, NADPH oxidase, etc.), hydro-
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ABSTRACT
Background & objectives: Crimean-Congo haemorrhagic fever (CCHF) can be fatal with bleeding, shock and
disseminated intravascular coagulopathy (DIC). Although similar genetic strains have been defined, the causes of
the clinical differences between the cases are yet to be found. We aimed to demonstrate the balance between
oxidant and antioxidant system in CCHF.
Methods: In this study, the patient group consisted of 72 cases with a positive diagnosis of CCHF according to
PCR/ELISA outcome among the patients referred to Cumhuriyet University, Medical Faculty in 2010. A total of
74 volunteers who were not having any viral or metabolic disease, non-smokers and age and sex matched with the
patients group were enrolled as the control group. Both in the controls and the patients, individuals aged under
16 yr were defined as group 1 and the individuals aged over 16 yr as group 2. The serum samples were stored at
–80°C until the study was carried out. All the samples were simultaneously thawed. In these cases, total antioxidant
capacity (TAC), total oxidative status (TOS), oxidative stress index (OSI), lipid peroxide (LPO), paraoxonase
(PON) and arylesterase were analyzed with the ELISA method. OSI was calculated.
Results: Levels of TOS, OSI and LPO were found significantly higher in CCHF patients in both the groups
(p <0.05), whereas levels of TAC, PON1 and arylesterase were lower in CCHF patients compared to the controls,
but low level of TAC in the group 1 was not statistically significant.
Interpretation & conclusion: Our study demonstrated increased oxidative stress in CCHF patients in both groups
1 and 2. In order to prevent tissue damage which might be developed due to the oxidative stress in CCHF patients,
further comprehensive studies should be conducted to define whether the adding antioxidants to the treatment
would be helpful or not.
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quinone, flavins, thiols, catecholamines, ferredoxin and
reduced nucleotides5–6. All the biomolecules (protein,
lipid, nucleic acids and the carbohydrates) are affected
by free radicals. When production of free radicals (in the
cases of oxidative stress conditions) exceeds antioxidant
defense system, permanent tissue damage and chronic dis-
eases develop7. Reactive oxygen species have been shown
to play an important role in the pathogenesis of rheuma-
toid arthritis, atherosclerosis, acute and chronic inflam-
matory diseases8. In CCHF patients, viral infection, high
fever and increased breakdown products are likely to clean
the oxidation paths and resultant increased oxidative stress
may trigger the prognosis of the disease. If oxidative stress
exceeds the antioxidant capacity or if oxidative stress re-
mains unchanged and antioxidant capacity decreases, tis-
sue damage develops due to oxidative damage.
Increased ROS react with the particularly double
bonds of multi unsaturated fatty acid, resulting in occur-
rence of malondialdehyde (MDA) compounds those are
the final products of lipid peroxides9. Recent studies have
shown that paraoxonase (PON1) has an antioxidant ef-
fect against lipid peroxidation caused by free radicals on
cell membranes and lipoproteins10. Paraoxonase multi-
gene family located in q21-22 region of the 7th chromo-
some in human consists of three members called PON1,
PON2 and PON311. PON1, is a calcium dependent ester
hydrolase both having paraoxonase and arylesterase
activity. This is a protein mainly synthesized in the liver
and has hydrolytic effect on several substrates, including
serum paraoxonase enzyme-1, organophosphates,
arylesterases and lactones that are released to serum cir-
culation12. Primary physiologic role of PON1 is not fully
understood, although recent studies reported it to be as-
sociated with the HDL cholesterol and to play a protec-
tive role against the oxidative modification of LDL
cholesterol, preventing lipid peroxidation and to have an-
tioxidant and anti-inflammatory characteristics13. Further-
more, in the patients who suffer from the diseases char-
acterized by oxidative damage, HDL was found to be more
prone to peroxidation and correlated with the decreased
activity of PON114.
In this study, we aimed to demonstrate the balance
between oxidant and antioxidant systems by measurement
of total antioxidant capacity (TAC), total oxidative status
(TOS), oxidative stress index (OSI), lipid peroxide (LPO),
paraoxonase (PON) and arylesterase levels in order to
get knowledge about the antioxidant system in CCHF pa-
tients.
MATERIAL & METHODS
In this study, serum samples were taken from the
patients referred to Cumhuriyet University Medical Fac-
ulty, Department of Emergency Medicine, Department
of Infectious Diseases and Department of Pediatrics with
a history of tick bite in 2010. Out of these samples, 72
cases with a positive diagnosis of CCHF according to the
PCR/ELISA results from the Refik Saydam Hygiene Cen-
ter of Ankara, Turkey were selected for the study. As the
control group; blood specimens were collected from age,
and sex matched 30 persons aged <16 yr and 44 persons
aged >16 yr old, those without history of viral or meta-
bolic disorder, and are non-smokers. Both in the controls
and the patients, individuals aged <16 yr were defined as
group 1 and the individuals aged >16 yr as group 2. The
serum samples of both groups were centrifuged at 4000
rpm for 5 min using Hettich Universal 30 centrifuge de-
vice. The serum samples were stored at –80°C until use.
All the samples were simultaneously dissolved or thawed.
In these cases, TAC, TOS, PON and arylesterase were
analyzed in Synchron LX 20 autoanalyzer using Rel As-
say Diagnostic brand kits and Cayman LPO was analyzed
in the assay kit “Grifols” brand “Triturus” model ELISA
device. OSI was calculated.
Total antioxidant capacity (TAC)
TAC levels were measured using commercially avail-
able kits (Relassay, Turkey). The novel automated method
is based on the bleaching of characteristic color of a more
stable ABTS [2,22-Azino-bis (3-ethylbenzothiazoline-6-
sulfonic acid)] radical cation by antioxidants. The assay
has excellent precision values, which are <3%. The re-
sults were expressed as mmol Trolox equivalent/l15.
Total oxidant status (TOS)
TOS levels were measured using commercially
available kits (Relassay, Turkey). In this new method,
oxidants present in the sample oxidized the ferrous
ion-o-dianisidine complex to ferric ion. The oxidation
reaction was enhanced by glycerol molecules abundantly
present in the reaction medium. The ferric ion produced
a colored complex with xylenol orange in an acidic
medium. The colour intensity, which could be
measured spectrophotometrically, was related to the to-
tal amount of oxidant molecules present in the sample.
The assay was calibrated with hydrogen peroxide,
and the results were expressed in terms of micromolar
hydrogen peroxide equivalent per liter (μmol H2O2
equivalent/l)16.
Oxidative stress index (OSI)
The ratio of TOS to TAC was accepted as the OSI.
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to μmol/l, and the OSI value was calculated according to
the following formula17–19:
study are shown in Table 1. Out of the control group aged
<16 yr, 23 (76.7%) were males and 7 (23.3%) were females
with a mean age of 10.2 ± 4.44 yr. Of the patients group, 22
(78.6%) of 28 persons were males and 6 (21.4%) were fe-
male patients with a mean age of 10.14 ± 4.03 yr (Table 1).
Of the group aged >16 yr, 27 (61.4%) of 44 persons were
males and 17 (38.6%) were females with a mean age of
45.22 ± 16.33 yr. Of the patients group, 28 (63.6%) of 44
persons were males and 16 (36.4%) were female patients
with a mean age of 52.11 ± 17.83 yr. On comparison, no
significant difference was found between the controls and
patients in terms of age and gender (p >0.05).
Levels of TOS, OSI and LPO were found significantly
higher in CCHF patients in the groups 1 and 2 compared
to the controls (p <0.05) (Table 1). Despite levels of TAC,
PON1 and arylesterase were lower in CCHF positive cases
in the groups 1 and 2 compared to the controls, low level
of TAC was not statistically significant (Table 1).
DISCUSSION
Redox balance is a crucial factor for numerous cellu-
lar functions. This balance provides important contribu-
tion to the pathophysiology of several diseases, includ-
ing viral infections. Virus induced oxidative stress may
mediate to release of proinflammatory cytokines. In some
cases, inflammatory response of the host may contribute
to the pathophysiology of the disease20. Levels of anti-
oxidant enzymes are sensitive to oxidative stress. ROS’s
increase or decrease depends on the disease. In this study,
levels of TOS, OSI and LPO were found significantly
increased in the patients in both the groups compared to
the controls (p <0.05). Despite levels of TAC, PON1 and
arylesterase were lower in CCHF positive cases in the
groups 1 and 2 compared to the controls, low level of
Table 1. Demographic features and comparison of the patients and controls in terms of the measured parameters
Features Group 1 (<16 yr) p-value Group 2 (>16 yr) p-value
Control CCHF patients Control CCHF patients
n = 30 n = 28  n = 44 n = 44
Age 10.20 ± 4.44 10.14 ± 4.03 45.22 ± 16.33 52.11 ± 17.83
Gender
Female 7 (23.3) 6 (21.4) 17 (38.6) 16 (36.4)
Male 23 (76.7) 22 (78.6) 27 (61.4) 28 (63.6)
TOS (μmol H2O2 equiv/l) 3.98 ± 1.68 6.47 ± 2.43 0 6.49 ± 2.42 9.32 ± 3.09 0
TAC (μmol trolox equiv/l) 1.25 ± 0.31 1.23 ± 0.21 0.737 1.22 ± 0.25 0.94 ± 0.29 0
OSI 0.32 ± 0.13 0.53 ± 0.20 0 0.55 ± 0.21 1.07 ± 0.43 0
LPO (μmol/l) 1.52 ± 0.62 2.51 ± 0.55 0 1.34 ± 0.68 2.46 ± 1.14 0
PON1 (U/L) 80.18 ± 19.35 55.20 ± 24.60 0 86.36 ± 24.40 57.2  ± 14.08 0
Arylesterase (U/L) 23,968 ± 506 22,126 ± 2065 0 16.205± 2840 14,127 ± 1771 0
Figures in parentheses indicate percentages.
 TAC (μmol Trolox equivalent/l)
OSI (Arbitrary unit) =
TOS (μmol H2O2 equivalent/l)
Paraoxonase and arylesterase
Paraoxonase and arylesterase activities were mea-
sured by using commercially available kits (Relassay,
Turkey). The rate of paraoxon hydrolysis (diethyl p-
nitrophenyl phosphate) was measured by monitoring the
increase of absorption at 412 nm at 37°C. The amount of
generated p-nitrophenol was calculated from the molar
absorption coefficient at pH 8.5, which was 18.290
M-1 cm-1. Paraoxonase activity was expressed as U/L se-
rum. Phenyl acetate was used as a substrate to measure
the arylesterase activity. Enzymatic activity was calcu-
lated from the molar absorption coefficient of the pro-
duced phenol, 1310 M-1 cm-1. One unit of arylesterase
activity was defined as 1 μmol phenol generated per
minute under the above conditions and expressed as U/L.
Statistical analysis
Data from the study were loaded to SPSS 15 soft-
ware. Analysis of the data was carried out using Chi-
square, independent two-sample t-test and correlation test.
The data were expressed as numbers and the level of sig-
nificance was considered as 0.05.
This study was conducted with the approval of the
Cumhuriyet University Medical Faculty Ethics Commit-
tee dated 9/12/2009 and B.30.2.CUM.0.1H.00.00/27 num-
bered decision for compliance.
RESULTS
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TAC was not statistically significant. These results sug-
gested that oxidative stress had increased, and the anti-
oxidant system decreased in CCHF patients related to the
viral infection.
In our previous study, we showed increase in the level
of SOD (superoxide dismutase) no change in the levels
of CAT (catalase), GSHP (glutathione peroxidase) and
GR (glutathione reductase) decrease in the level of vita-
min E and increase in the levels of plasma and erythro-
cyte MDA (malondi-aldehyde) in CCHF patients21.
Güner et al22 showed that the level of TOS signifi-
cantly increased in CCHF patients compared to the con-
trols. This finding supports our study. Gil et al23 demon-
strated oxidative stress to be increased in the patients with
dengue fever, which is another viral haemorrhagic fever,
compared to the controls. Akaike et al24 showed that the
levels of superoxide anion and hydrogen peroxides in-
crease in viral infections. All these studies indicate that
the oxidative stress increases in relation to viral infec-
tion, and this result is consistent with our findings.
Increased oxidative stress may lead to the hepatic cel-
lular damage25. Several studies demonstrated increased
levels of AST, ALT, ALP, GGT and LDH in CCHF pa-
tients26. Oxidative stress is likely to provide contribution
to the increased levels of AST, ALT, ALP, GGT and LDH
in CCHF patients. Halliwell et al27, reported lipid
peroxidation might be increased due to the inflammatory
response in viral infections and increased level of anti-
oxidant was the earliest indicator of decreased oxidative
stress during the healing process. LPO and ROS were
shown to cause fibrosis in the liver tissue in viral infec-
tions with insufficient antioxidant capacity28–29.
In a study, it was reported that PON1 might reduce
lipid peroxides such as oxidated polyunsaturated
fatty acids and H2O2
30. Under oxidative stress, lipid
peroxidation occurs in the lipids found not only in LDL,
but also in HDL31. PON1 was reported to protect both
the LDL and HDL against oxidation30. PON1 is proposed
to provide contribution to antioxidant impact through
HDL and might be associated with the metal ion chela-
tion and/or peroxidase like activity under the inhibitor
effect of HDL. HDL-PON1 long chain oxidized phos-
pholipids have the ability to hydrolyze32. We found de-
creased levels of PON1/arylesterase in CCHF patients
both in groups 1 and 2 compared to the controls (p <0.05).
Low levels of PON1/arylesterase in CCHF patients may
be due to various factors; liver is known to be affected in
hepatic patients. PON1/arylesterase is synthesized in the
liver33 and low level of PON1/arylesterase in CCHF pa-
tients may be due to the expression. Recent studies re-
ported an opposite correlation between increased ROS
and paraoxonase-1/arylesterase which is an anti-oxidant
enzyme and, levels of PON1/arylesterase decreased when
ROSs increased35–36. Low levels of PON1/arylesterase
may be due to increased oxidative stress.
In an in vitro study by Kumon et al36, an opposite
correlation was reported between PON1 and IL-1 and
TNF-α; increased IL-1 and TNF-α led to decrease in se-
rum paraoxonase activity. In the studies on CCHF pa-
tients, levels of TNF-α, IL-1, and IL-6 were demonstrated
to increase37. Low levels of PON1/arylesterase may be
due to increased TNF-α and IL.
Tarçýn et al38 stated that the most important factor in
paraoxonase-1/arylesterase activity was age; and the en-
zyme activity, which was maximum in the infants and
gradually decreased with the age38. In our study, levels
of paraoxonase-1/arylesterase were found to be lower in
the persons aged <16 yr than in those >16 yr old (p >0.05).
Our finding was not at all parallel to that in the study by
Tarcýn et al38. Low levels of paraoxonase-1/arylesterase
in the children compared to the adults in our study group
might be attributed to the limited number of the cases.
In conclusion, oxidative stress was found to be in-
creased in CCHF patients both in the groups 1 and 2.
Increased oxidative stress has been emphasized to cause
damage in many tissues. There are no studies on this sub-
ject in CCHF patients. In order to prevent tissue damage
that might be developed due to the oxidative stress in
CCHF patients, further comprehensive studies should be
conducted to define whether adding antioxidants to the
treatment would be helpful or not.
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